Bluebird Bio Stock Analysis

Bluebird Stock Analysis Notes

About 95.0% of the company shares are held by institutions such as insurance companies. The book value of Bluebird Bio was currently reported as 2.08. The company has Price/Earnings To Growth (PEG) ratio of 0.32. Bluebird Bio recorded a loss per share of 0.63. The entity had not issued any dividends in recent years. The firm had 1544:1000 split on the 5th of November 2021. bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people. For more info on Bluebird Bio please contact Nick Leschly at 339 499 9300 or go to https://www.bluebirdbio.com.

Bluebird Bio Investment Alerts

Bluebird Bio Upcoming and Recent Events

Bluebird Largest EPS Surprises

View All Earnings Estimates

Bluebird Bio SEC Filings

Bluebird Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 465.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bluebird Bio's market, we take the total number of its shares issued and multiply it by Bluebird Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bluebird Profitablity

Management Efficiency

Bluebird Bio has return on total asset (ROA) of (0.1501) % which means that it has lost $0.1501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4781) %, meaning that it created substantial loss on money invested by shareholders. Bluebird Bio's management efficiency ratios could be used to measure how well Bluebird Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2023, Return on Investment is expected to decline to -103.27. In addition to that, Return on Average Assets is expected to decline to -0.51. At present, Bluebird Bio's Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Assets Non Current is expected to grow to about 403.8 M, whereas Tax Assets are forecasted to decline to about 620.1 K.

Technical Drivers

As of the 4th of December, Bluebird Bio shows the Risk Adjusted Performance of 0.0579, downside deviation of 4.77, and Mean Deviation of 3.75. Bluebird Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to break down and analyze data for nineteen technical drivers for Bluebird Bio, which can be compared to its rivals. Please confirm Bluebird Bio variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Bluebird Bio is priced correctly, providing market reflects its regular price of 4.26 per share. Given that Bluebird Bio has jensen alpha of 0.28, we suggest you to validate Bluebird Bio's prevailing market performance to make sure the company can sustain itself at a future point.

Bluebird Bio Price Movement Analysis

Bluebird Bio Insider Trading Activities

Bluebird Bio Technical and Predictive Indicators

Bluebird Bio Forecast Models

Bluebird Bio's time-series forecasting models are one of many Bluebird Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bluebird Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bluebird Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bluebird shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bluebird Bio. By using and applying Bluebird Stock analysis, traders can create a robust methodology for identifying Bluebird entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bluebird analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bluebird analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bluebird Bio stock analysis indicators help investors evaluate how Bluebird Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bluebird Bio shares will generate the highest return on investment. By understating and applying Bluebird Bio stock analysis, traders can identify Bluebird Bio position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.

Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Bluebird Bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.